Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 11/03/17
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 08/22/22
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Safety Study of 212Pb-Pentixather Radioligand Therapy | NCT05557708 | Yusuf Menda | user2@example.com | None | 2024-07-01 | 2028-06-30 | 2029-06-30 | - | - | 2025-07-14 |
| Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors | NCT03335670 | Yusuf Menda | user2@example.com | None | 2017-11-03 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent | NCT05111509 | Yusuf Menda | user2@example.com | None | 2022-08-22 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |